(Last updated: September 2021)

Appendix B: Panel Roster and Financial Disclosures

Hepatitis C Virus

Hepatitis C Virus 
Member Institution Financial Disclosure
Company Relationship
Meena Bansal Mount Sinai, Icahn School of Medicine None N/A
Arthur Kim Harvard Medical School Kintor Pharmaceuticals Data Monitoring Committee
Nina Kim University of Washington, School of Medicine and School of Public Health Gilead FOCUS grant Research Support (paid to institution)
Susanna Naggie Duke University, School of Medicine Vir Biotechnology Equity Interest
Vir Biotechnology

Bio Marin

Theratechnologies
Scientific Advisor Board
AbbVie

Gilead Sciences
Research Support (paid to institution)
FHI360

PRA/BMS
Adjudication Committee
Mark Sulkowski Johns Hopkins University, School of Medicine Arbutus

Assembly Bio

Atea

Antios

AbbVie

Gilead Sciences

Virion

 
Scientific Advisory Board
AbbVie

Assembly Bio

Gilead Sciences

Janssen

Contrafect

EigerBio
Research Support (paid to institution)
Merceditas Villanueva Yale University, School of Medicine None N/A
David Wyles* Denver Health Medical Center and University of Colorado, Denver, School of Medicine Gilead Sciences Research Support (paid to institution)
* Group lead

Note: Members were asked to disclose all relationships from 12 months prior to the updated date. The period of reporting is from July 2021 through July 2022.

 

Download Guidelines